Showing results (1921-1930 of 1,947) with videos related to

Sort By:
Pageof 195
Experimental and Molecular Pathology|September 15, 2014
Alcoholic and non-alcoholic steatohepatitisManuela G Neuman, Samuel W French, Barbara A French, et al.
Journal of Hematology|April 22, 2024
Effective Management of Polycythemia Vera With Ropeginterferon Alfa-2b TreatmentShan Shan Suo, Rong Feng Fu, Albert Qin, et al.
Journal of Integrative Medicine|June 1, 2025
International clinical practice guideline on the use of traditional Chinese medicine for functional dyspepsia (2025)Sheng-Sheng Zhang, Lu-Qing Zhao, Xiao-Hua Hou, et al.
Journal of Medicinal Chemistry|December 5, 2025
Discovery of Atirmociclib (PF-07220060): A Potent and Selective CDK4 InhibitorGary M Gallego, Cynthia Palmer, Suvi Orr, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 2, 2024
Survey of Pharmaceutical Industry's Best Practices around In Vitro Transporter Assessment and Implications for Drug Development: Considerations from the International Consortium for Innovation and Quality for Pharmaceutical Development Transporter Working GroupHelen E Rollison, Pallabi Mitra, Hugues Chanteux, et al.
Chinese Medical Journal|August 5, 2017
Characteristics, Management, and Outcomes of Acute Heart Failure in the Emergency Department: A Multicenter Registry Study with 1-year Follow-up in a Chinese Cohort in BeijingGuo-Gan Wang, Si-Jia Wang, Jian Qin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 27, 2026
Drug-drug interaction assessments of clinical transporter inhibition: Learnings from the Transporter Working Group of the International Consortium for Innovation and Quality in Pharmaceutical DevelopmentRucha S Sane, Pallabi Mitra, Yurong Lai, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2018
Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 casesJian-Feng Li, Yu-Ting Dai, Henrik Lilljebjörn, et al.
Nature Cancer|June 15, 2023
Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLCCaicun Zhou, Ziping Wang, Meili Sun, et al.
Leukemia|April 4, 2019
Blocking ATM-dependent NF-κB pathway overcomes niche protection and improves chemotherapy response in acute lymphoblastic leukemiaYa-Li Chen, Chao Tang, Meng-Yi Zhang, et al.
Pageof 195